JP2023536814A5 - - Google Patents

Info

Publication number
JP2023536814A5
JP2023536814A5 JP2023505846A JP2023505846A JP2023536814A5 JP 2023536814 A5 JP2023536814 A5 JP 2023536814A5 JP 2023505846 A JP2023505846 A JP 2023505846A JP 2023505846 A JP2023505846 A JP 2023505846A JP 2023536814 A5 JP2023536814 A5 JP 2023536814A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence identity
seq
nos
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023505846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023536814A (ja
JP7883479B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2021/050443 external-priority patent/WO2022025827A1/en
Publication of JP2023536814A publication Critical patent/JP2023536814A/ja
Publication of JP2023536814A5 publication Critical patent/JP2023536814A5/ja
Application granted granted Critical
Publication of JP7883479B2 publication Critical patent/JP7883479B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023505846A 2020-07-30 2021-07-30 細胞の増殖を刺激する方法 Active JP7883479B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10202007297P 2020-07-30
SG10202007297P 2020-07-30
PCT/SG2021/050443 WO2022025827A1 (en) 2020-07-30 2021-07-30 Method of stimulating proliferation of a cell

Publications (3)

Publication Number Publication Date
JP2023536814A JP2023536814A (ja) 2023-08-30
JP2023536814A5 true JP2023536814A5 (cg-RX-API-DMAC10.html) 2024-08-07
JP7883479B2 JP7883479B2 (ja) 2026-07-01

Family

ID=80038130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505846A Active JP7883479B2 (ja) 2020-07-30 2021-07-30 細胞の増殖を刺激する方法

Country Status (8)

Country Link
US (2) US12421515B2 (cg-RX-API-DMAC10.html)
EP (1) EP4107270A4 (cg-RX-API-DMAC10.html)
JP (1) JP7883479B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230049661A (cg-RX-API-DMAC10.html)
CN (1) CN116261461A (cg-RX-API-DMAC10.html)
AU (1) AU2021315341A1 (cg-RX-API-DMAC10.html)
CA (1) CA3187212A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022025827A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022218908A1 (en) * 2021-04-12 2022-10-20 Syddansk Universitet Mfap4 and treatment of fibrosis
EP4547843A2 (en) 2022-06-28 2025-05-07 Lerna Biopharma Pte. Ltd. Inhibitory nucleic acids for itfg1
JP2026519589A (ja) * 2023-05-31 2026-06-16 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 肝臓細胞の再生

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932442A (en) * 1997-09-23 1999-08-03 Incyte Pharmaceuticals, Inc. Human regulatory molecules
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
CA2566286A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
EP3445385A4 (en) * 2016-04-18 2019-11-20 The Trustees of Columbia University in the City of New York THERAPEUTIC GOALS INVOLVED IN THE PROGRESSION OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
CA3022319A1 (en) * 2016-05-06 2017-11-09 Tod M. Woolf Improved methods for genome editing with and without programmable nucleases
AU2019216264B2 (en) * 2018-01-31 2023-08-31 Heparegenix Gmbh Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
CN111154760A (zh) * 2020-01-16 2020-05-15 中国药科大学 抑制人PCSK9基因表达的siRNA及其应用

Similar Documents

Publication Publication Date Title
EP3472362B1 (en) Papd5 and papd7 inhibitors for treating an hepatitis b infection
AU2014351482B2 (en) C/EBP alpha short activating RNA compositions and methods of use
JP7829035B2 (ja) アンギオテンシノゲン(agt)タンパク質の発現を阻害する組成物及び方法
CA2604532A1 (en) Small activating rna molecules and methods of use
JP2018536689A5 (cg-RX-API-DMAC10.html)
KR20070110135A (ko) 작은 간섭 rna 및 이를 포함하는 b형 간염 바이러스치료용 약학 조성물
CN116888263A (zh) 用于抑制血管生成素样3(angptl3)蛋白表达的组合物和方法
JP2026510791A (ja) インヒビンサブユニットベータe(inhbe)遺伝子の発現を阻害するための組成物および方法
JP2022512735A5 (cg-RX-API-DMAC10.html)
JP2024538859A5 (cg-RX-API-DMAC10.html)
Arbuthnot et al. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
WO2018193902A1 (ja) マイクロrnaによるb型肝炎ウイルスに対する抗ウイルス効果
Suzuki et al. Poly (ethylene Glycol)(PEG)–OligoRNA Hybridization to mRNA Enables Fine‐Tuned Polyplex PEGylation for Spleen‐Targeted mRNA Delivery
CN102028947B (zh) Fam3b基因的抑制剂和组合物及抑制方法以及脂肪肝的疗法和抑制剂的制药用途
WO2022026648A1 (en) Inhibition of incexact1 to treat heart disease
US20220220189A1 (en) Compositions and methods for treatment of hemochromatosis
CN100447243C (zh) HBV特异性干涉靶位点基因及其siRNA和其在抗HBV感染中的应用
CN101948544B (zh) FAT10基因siRNA重组模拟病毒及其制备方法和应用
CN117587006A (zh) 一种抑制肝脏细胞中LOC157273基因表达的siRNA、组合物及其应用
JP2025512771A5 (cg-RX-API-DMAC10.html)
JP2024529930A5 (cg-RX-API-DMAC10.html)
JP2022530937A (ja) オリゴ核酸分子及びその急性間欠性ポルフィリン症の治療における応用
CN107709561A (zh) 修饰的siRNA及含有该修饰的siRNA的药物组合物
JP2023529398A (ja) Mitf遺伝子を標的とする核酸分子及びその使用
CN118853673A (zh) 一种用于抑制DC624545的siRNA、修饰物、药物缀合物和应用